Is Defitelio Available in India and How Can Patients Access It?
Defitelio is not commercially available in India; however, patients can still access it through regulated pathways. It is indicated for the treatment of hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with complications following HSCT. Since it is not locally approved, access is possible only through the Named Patient Program (NPP) with a valid doctor’s prescription. Indian Pharma Network supports patients and hospitals by handling the complete process, including global sourcing, regulatory documentation, and secure delivery. This ensures access to genuine, high-quality medicine. For assistance, call +91-9654860915 or WhatsApp +91-9810469557 for quick guidance.
https://www.indianpharmanetwork.in/defibrotide-sodium/